TSHA logo

Taysha Gene Therapies (TSHA) EV/EBITDA

EV/EBITDA

-25.83
-1.38-5.64%

Thu, 28 Nov 2024 00:46:21 GMT

TSHA EV/EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TSHA EV/EBITDA Performance

PeriodPeriodEV/EBITDAEV/EBITDA
todaytoday-5.6%
1 m1 month-64.3%
3 m3 months-758.1%
6 m6 months-456.7%
ytdytd-980.8%
1 y1 year-2206.3%
5 y5 years-

TSHA EV/EBITDA High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month-8.09-219.3%-25.83at low
3 m3 months-2.64-878.4%-25.83at low
6 m6 months-2.54-916.9%-25.83at low
1 y1 year-0.85-2938.8%-25.83at low
3 y3 years-0.09<-9999.0%-25.83at low
5 y5 years-0.09<-9999.0%-31.19+17.2%
alltimeall time-0.09<-9999.0%-31.19+17.2%

Taysha Gene Therapies EV/EBITDA History

DateValue
2024
-25.83(+980.8%)
2023
-2.39(+236.6%)
DateValue
2022
-0.71(-66.2%)
2021
-2.10(-83.2%)
2020
-12.52

FAQ

  • What is Taysha Gene Therapies EV/EBITDA?
  • What is the all time high EV/EBITDA for Taysha Gene Therapies?
  • What is TSHA EV/EBITDA year-to-date change?
  • What is Taysha Gene Therapies EV/EBITDA year-on-year change?

What is Taysha Gene Therapies EV/EBITDA?

The current EV/EBITDA of TSHA is -25.83

What is the all time high EV/EBITDA for Taysha Gene Therapies?

Taysha Gene Therapies all-time high EV/EBITDA is -0.09

What is TSHA EV/EBITDA year-to-date change?

Taysha Gene Therapies EV/EBITDA has changed by -23.44 (-980.75%) since the beginning of the year

What is Taysha Gene Therapies EV/EBITDA year-on-year change?

Over the past year, TSHA EV/EBITDA has changed by -24.71 (-2206.25%)